CSS
VTVT icon

Cubist Systematic Strategies’s vTv Therapeutics VTVT Stock Holding History

Cubist Systematic Strategies’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-277
Closed -$17K – 3657
2021
Q3 		$17K Sell
277
-77
-22% -$5.8K ﹤0.01% 2892
2021
Q2 		$32K Buy
+354
New +$35.9K ﹤0.01% 2826

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cubist Systematic Strategies's VTVT Position: Q4 2021 in Review

Cubist Systematic Strategies sold out of vTv Therapeutics (VTVT) in Q4 2021, closing a stake of 277 shares — an estimated $17K sold.

Cubist Systematic Strategies first reported a position in VTVT in Q2 2021 and held it in 2 quarters. The position peaked at $32K in Q2 2021. 29 funds tracked by Wall St. Rank hold VTVT as of Q4 2021.

  • Cubist Systematic Strategies reported no remaining vTv Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Cubist Systematic Strategies sold 277 vTv Therapeutics shares in Q4 2021, an estimated $17K.
  • Cubist Systematic Strategies first reported a position in vTv Therapeutics in Q2 2021 and held it in 2 quarters.
  • Cubist Systematic Strategies's vTv Therapeutics position peaked at $32K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2021.

Based on Cubist Systematic Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.